Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.24 USD | -2.24% |
|
-7.26% | +24.17% |
Jul. 01 | Vanda Pharmaceuticals Says Federal Court Allows Patent Lawsuit Over Hetlioz | MT |
Jul. 01 | Vanda Pharmaceuticals Inc.(NasdaqGM:VNDA) dropped from Russell 2000 Value-Defensive Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.17% | 305M | |
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.56B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |
- Stock Market
- Equities
- VNDA Stock
- News Vanda Pharmaceuticals Inc.
- Transcript : Vanda Pharmaceuticals Inc., Q2 2022 Earnings Call, Aug 03, 2022